Do analysts recommend MTEX or SNYR?

Synergy CHC has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Mannatech. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Mannatech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is MTEX or SNYR more profitable?

Mannatech has a net margin of -6.90% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Mannatech's return on equity. Company Net Margins Return on Equity Return on Assets Mannatech -6.90% -2,383.34% -24.43% Synergy CHC -60.02% N/A -30.30%

Does the media prefer MTEX or SNYR?

In the previous week, Mannatech and Mannatech both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Mannatech's score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mannatech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Synergy CHC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NHTC or SNYR?

Synergy CHC has a consensus price target of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts plainly believe Synergy CHC is more favorable than Natural Health Trends. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Health Trends 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media favor NHTC or SNYR?

In the previous week, Natural Health Trends and Natural Health Trends both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Natural Health Trends' score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Health Trends 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Synergy CHC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer NAII or SNYR?

Synergy CHC has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Natural Alternatives International. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media prefer NAII or SNYR?

In the previous week, Natural Alternatives International and Natural Alternatives International both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Natural Alternatives International's score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natural Alternatives International 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Synergy CHC 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend DRMA or SNYR?

Synergy CHC has a consensus price target of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Dermata Therapeutics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dermata Therapeutics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Do analysts rate SNYR or ATPC?

Synergy CHC currently has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synergy CHC is more favorable than Agape ATP. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Synergy CHC 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Agape ATP 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SNYR or ATPC more profitable?

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity. Company Net Margins Return on Equity Return on Assets Synergy CHC -60.02% N/A -30.30% Agape ATP -85.94% -5.47% -4.94%

Synergy CHC (SNYR) Competitors

$0.09 0.00 (0.00%)

As of 09/18/2026

Compare

SNYR vs. MTEX, NHTC, NAII, DRMA, and ATPC

Should you buy Synergy CHC stock or one of its competitors? Synergy CHC's main competitors and comparable companies include Mannatech (MTEX), Natural Health Trends (NHTC), Natural Alternatives International (NAII), Dermata Therapeutics (DRMA), and Agape ATP (ATPC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "personal care products" industry.

How does Synergy CHC compare to Mannatech?

Mannatech (NASDAQ:MTEX) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, media sentiment, valuation, institutional ownership, analyst recommendations and earnings.

Synergy CHC has a consensus target price of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts plainly believe Synergy CHC is more favorable than Mannatech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mannatech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

13.0% of Mannatech shares are owned by institutional investors. 47.5% of Mannatech shares are owned by company insiders. Comparatively, 32.9% of Synergy CHC shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Mannatech and Mannatech both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Mannatech's score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mannatech	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Synergy CHC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mannatech has a net margin of -6.90% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Mannatech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mannatech	-6.90%	-2,383.34%	-24.43%
Synergy CHC	-60.02%	N/A	-30.30%

Synergy CHC has lower revenue, but higher earnings than Mannatech. Mannatech is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mannatech	$108.04M	0.14	-$15.21M	-$3.91	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

Mannatech has a beta of 0.75, indicating that its stock price is 25% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, indicating that its stock price is 125% less volatile than the broader market.

Summary

Synergy CHC beats Mannatech on 8 of the 15 factors compared between the two stocks.

How does Synergy CHC compare to Natural Health Trends?

Natural Health Trends (NASDAQ:NHTC) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, media sentiment, profitability, risk, dividends, earnings and institutional ownership.

In the previous week, Natural Health Trends and Natural Health Trends both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Natural Health Trends' score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natural Health Trends	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Synergy CHC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

10.1% of Natural Health Trends shares are owned by institutional investors. 12.9% of Natural Health Trends shares are owned by company insiders. Comparatively, 32.9% of Synergy CHC shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Natural Health Trends has a net margin of -4.51% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Natural Health Trends' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natural Health Trends	-4.51%	-8.00%	-4.58%
Synergy CHC	-60.02%	N/A	-30.30%

Natural Health Trends has higher revenue and earnings than Synergy CHC. Natural Health Trends is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natural Health Trends	$39.78M	0.23	-$880K	-$0.16	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

Synergy CHC has a consensus price target of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts plainly believe Synergy CHC is more favorable than Natural Health Trends.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natural Health Trends	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Natural Health Trends has a beta of 0.92, suggesting that its stock price is 8% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, suggesting that its stock price is 125% less volatile than the broader market.

Summary

Natural Health Trends beats Synergy CHC on 8 of the 15 factors compared between the two stocks.

How does Synergy CHC compare to Natural Alternatives International?

Natural Alternatives International (NASDAQ:NAII) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and earnings.

32.4% of Natural Alternatives International shares are held by institutional investors. 20.8% of Natural Alternatives International shares are held by insiders. Comparatively, 32.9% of Synergy CHC shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Synergy CHC has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher probable upside, analysts clearly believe Synergy CHC is more favorable than Natural Alternatives International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Natural Alternatives International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Natural Alternatives International has a beta of 0.36, meaning that its stock price is 64% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, meaning that its stock price is 125% less volatile than the broader market.

In the previous week, Natural Alternatives International and Natural Alternatives International both had 1 articles in the media. Synergy CHC's average media sentiment score of 0.61 beat Natural Alternatives International's score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Natural Alternatives International	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Synergy CHC	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Synergy CHC has lower revenue, but higher earnings than Natural Alternatives International. Natural Alternatives International is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Natural Alternatives International	$129.86M	0.09	-$13.57M	-$2.39	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

Natural Alternatives International has a net margin of -10.13% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Natural Alternatives International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Natural Alternatives International	-10.13%	-12.21%	-5.30%
Synergy CHC	-60.02%	N/A	-30.30%

Summary

Synergy CHC beats Natural Alternatives International on 9 of the 15 factors compared between the two stocks.

How does Synergy CHC compare to Dermata Therapeutics?

Dermata Therapeutics (NASDAQ:DRMA) and Synergy CHC (NASDAQ:SNYR) are both small-cap consumer staples companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

8.7% of Dermata Therapeutics shares are owned by institutional investors. 21.9% of Dermata Therapeutics shares are owned by insiders. Comparatively, 32.9% of Synergy CHC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Dermata Therapeutics has a beta of 0.69, indicating that its stock price is 31% less volatile than the broader market. Comparatively, Synergy CHC has a beta of -0.25, indicating that its stock price is 125% less volatile than the broader market.

Synergy CHC has a consensus price target of $6.25, indicating a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, analysts clearly believe Synergy CHC is more favorable than Dermata Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dermata Therapeutics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Synergy CHC had 1 more articles in the media than Dermata Therapeutics. MarketBeat recorded 1 mentions for Synergy CHC and 0 mentions for Dermata Therapeutics. Synergy CHC's average media sentiment score of 0.61 beat Dermata Therapeutics' score of 0.00 indicating that Synergy CHC is being referred to more favorably in the news media.

Company	Overall Sentiment
Dermata Therapeutics	Neutral
Synergy CHC	Positive

Dermata Therapeutics has a net margin of 0.00% compared to Synergy CHC's net margin of -60.02%. Synergy CHC's return on equity of 0.00% beat Dermata Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dermata Therapeutics	N/A	-166.66%	-130.13%
Synergy CHC	-60.02%	N/A	-30.30%

Dermata Therapeutics has higher earnings, but lower revenue than Synergy CHC. Dermata Therapeutics is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dermata Therapeutics	N/A	N/A	-$7.56M	-$4.39	N/A
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A

Summary

Synergy CHC beats Dermata Therapeutics on 11 of the 15 factors compared between the two stocks.

How does Synergy CHC compare to Agape ATP?

Synergy CHC (NASDAQ:SNYR) and Agape ATP (NASDAQ:ATPC) are both small-cap consumer staples companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, media sentiment, profitability and earnings.

0.0% of Agape ATP shares are held by institutional investors. 32.9% of Synergy CHC shares are held by insiders. Comparatively, 2.0% of Agape ATP shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Agape ATP has lower revenue, but higher earnings than Synergy CHC. Agape ATP is trading at a lower price-to-earnings ratio than Synergy CHC, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$27.70M	0.05	-$12.34M	-$1.40	N/A
Agape ATP	$1.52M	1.47	-$2.28M	-$0.74	N/A

Synergy CHC currently has a consensus price target of $6.25, suggesting a potential upside of 6,806.08%. Given Synergy CHC's stronger consensus rating and higher possible upside, equities research analysts plainly believe Synergy CHC is more favorable than Agape ATP.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Agape ATP	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Synergy CHC has a net margin of -60.02% compared to Agape ATP's net margin of -85.94%. Synergy CHC's return on equity of 0.00% beat Agape ATP's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Synergy CHC	-60.02%	N/A	-30.30%
Agape ATP	-85.94%	-5.47%	-4.94%

Synergy CHC has a beta of -0.25, suggesting that its share price is 125% less volatile than the broader market. Comparatively, Agape ATP has a beta of 0.4, suggesting that its share price is 60% less volatile than the broader market.

In the previous week, Synergy CHC had 1 more articles in the media than Agape ATP. MarketBeat recorded 1 mentions for Synergy CHC and 0 mentions for Agape ATP. Synergy CHC's average media sentiment score of 0.61 beat Agape ATP's score of 0.00 indicating that Synergy CHC is being referred to more favorably in the media.

Company	Overall Sentiment
Synergy CHC	Positive
Agape ATP	Neutral

Summary

Synergy CHC beats Agape ATP on 10 of the 16 factors compared between the two stocks.

Get Synergy CHC News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNYR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SNYR vs. The Competition

Export

Metric	Synergy CHC	Personal Care Products Industry	Consumer Staples Sector	NASDAQ Exchange
Market Cap	$1.37M	$23.30B	$15.71B	$13.28B
Dividend Yield	N/A	5.10%	3.27%	12.57%
P/E Ratio	-0.06	21.23	14.16	25.70
Price / Sales	0.05	12.94	262,949.03	90.85
Price / Cash	N/A	27.44	56.96	52.76
Price / Book	-0.04	2.88	4.31	6.32
Net Income	-$12.34M	$1.13B	$837.18M	$359.73M
7 Day Performance	N/A	-1.55%	-1.16%	0.17%
1 Month Performance	N/A	-5.84%	-4.40%	-3.27%
1 Year Performance	N/A	-15.98%	10.13%	5.58%

Synergy CHC Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SNYR Synergy CHC	3.2905 of 5 stars	$0.09 flat	$6.25 +6,806.1%	N/A	$1.37M	$27.70M	N/A	40
MTEX Mannatech	0.3864 of 5 stars	$7.85 -4.2%	N/A	-10.7%	$15.15M	$108.04M	N/A	250	Positive News Analyst Upgrade
NHTC Natural Health Trends	0.5577 of 5 stars	$1.51 +0.4%	N/A	-76.7%	$12.92M	$39.78M	N/A	140	News Coverage
NAII Natural Alternatives International	0.7143 of 5 stars	$1.99 +0.8%	N/A	-40.9%	$12.46M	$141.87M	N/A	290	News Coverage Gap Up
DRMA Dermata Therapeutics	0.5922 of 5 stars	$1.15 +1.8%	N/A	-78.5%	$4.62M	N/A	N/A	8	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SNYR) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Synergy CHC (SNYR) Competitors

SNYR vs. MTEX, NHTC, NAII, DRMA, and ATPC

How does Synergy CHC compare to Mannatech?

Summary

How does Synergy CHC compare to Natural Health Trends?

Summary

How does Synergy CHC compare to Natural Alternatives International?

Summary

How does Synergy CHC compare to Dermata Therapeutics?

Summary

How does Synergy CHC compare to Agape ATP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Synergy CHC (SNYR) Competitors

SNYR vs. MTEX, NHTC, NAII, DRMA, and ATPC

How does Synergy CHC compare to Mannatech?

Do analysts recommend MTEX or SNYR?

Do insiders & institutionals hold more shares of MTEX or SNYR?

Does the media prefer MTEX or SNYR?

Is MTEX or SNYR more profitable?

Which has stronger valuation and earnings, MTEX or SNYR?

Which has more volatility & risk, MTEX or SNYR?

Summary

How does Synergy CHC compare to Natural Health Trends?

Does the media favor NHTC or SNYR?

Do institutionals and insiders have more ownership in NHTC or SNYR?

Is NHTC or SNYR more profitable?

Which has stronger valuation & earnings, NHTC or SNYR?

Do analysts prefer NHTC or SNYR?

Which has more risk and volatility, NHTC or SNYR?

Summary

How does Synergy CHC compare to Natural Alternatives International?

Do insiders & institutionals hold more shares of NAII or SNYR?

Do analysts prefer NAII or SNYR?

Which has more risk & volatility, NAII or SNYR?

Does the media prefer NAII or SNYR?

Which has stronger earnings & valuation, NAII or SNYR?

Is NAII or SNYR more profitable?

Summary

How does Synergy CHC compare to Dermata Therapeutics?

Do insiders and institutionals believe in DRMA or SNYR?

Which has more volatility & risk, DRMA or SNYR?

Do analysts recommend DRMA or SNYR?

Does the media prefer DRMA or SNYR?

Is DRMA or SNYR more profitable?

Which has better valuation & earnings, DRMA or SNYR?

Summary

How does Synergy CHC compare to Agape ATP?

Do insiders and institutionals believe in SNYR or ATPC?

Which has preferable valuation & earnings, SNYR or ATPC?

Do analysts rate SNYR or ATPC?

Is SNYR or ATPC more profitable?

Which has more volatility & risk, SNYR or ATPC?

Does the media refer more to SNYR or ATPC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SNYR vs. The Competition

Synergy CHC Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools